microdosing glp 1 alzheimer's There isn't enough data to confirm that GLP-1s can help you live longer, says UNC Hospitals clinical pharmacist practitioner Anne Komé. But it could help clinicians optimize therapy for patients who Neuroprotective Actions of Glucagon-Like Peptide-1

Chronic diarrhea persisting beyond four weeks, even if mild, requires investigation to exclude conditions such as microscopic colitis, bile acid malabsorption, or exocrine pancreatic insufficiency

There's also a common trap worth naming

In OASIS 4 , oral semaglutide 25 mg produced about 13.6% mean weight loss at 64 weeks vs 2.2% with placebo (with higher ontreatment results reported)

The reviews found little to no difference between the drugs and placebo when looking at major cardiovascular events, mortality, or quality of life

Tresiba has no role in weight management

Hepatic Steatosis : Recently, a sub-study of the phase 3 clinical trial SURPASS-3 showed that, among patients receiving metformin and/or SGLT2 inhibitors, the addition of tirzepatide (10 or 15 mg) as compared to insulin degludec was able to significantly reduce hepatic fat content (evaluated by magnetic resonance) after 52 weeks of treatment